NCT03486379View on ClinicalTrials.gov

Folfiri as Third Line of Treatment

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2017

Study Completion Date

March 23, 2018

Conditions
Gastric CancerRamucirumabThird Line
All Listed Sponsors
lead

IRCCS Cancer Referral Center of Basilicata

OTHER

NCT03486379 - Folfiri as Third Line of Treatment | Biotech Hunter | Biotech Hunter